Genetic Identification and Risk Factor Analysis of Asymptomatic Bacterial Colonization on Cardiovascular Implantable Electronic Devices

Table 5

Comorbidities and drug application.

	DNA positive; ()	DNA negative; ()
Chronic heart disease	12	14	0.669	0.413
Coronary heart disease	8	10	0.216	0.642
Hypertension	14	22	0.02	0.886
Atrial fibrillation			Fisher	0.631
Paroxysmal	6	5
Persistent	3	6
Permanent	3	5
Dilated cardiomyopathy	6	6	Fisher	0.526
Diabetes	7	8	0.372	0.542
Renal insufficiency	6	2	Fisher	0.053
Chronic systolic HF	6	11		0.672
COPD	2	3	Fisher	1.0
Immunosuppressor	1	2	Fisher	1.0
Warfarin	1	2	Fisher	1.0
Antiplatelet drug use	20	15	8.026	0.005
Antibiotic use	11	3	10.741	0.001
Malignancy	1	1	Fisher	1.0
Bacterial infection history	29	11	36.787	0.0001
Surgical history	3	4	Fisher	1.0

HF, heart failure; COPD, chronic obstructive pulmonary disease.